5Allemann E, Guvny R, Doelker E. Drug-loaded nanoparticlesprepatration methods and drug argeting issues [ J ]. Eur J Pharm Biopharm, 1993, 39(5) : 173-191.
6Soma CE, Dubernet C, Barratt G, et al. Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicinloaded nanoparticles on M5067 cells in vitro[J]. J Control Release,2000, 68(2) :283-289.
7Gupta PK, Hung CT, Rao NS. Ultrastructural disposition of adriamycin associated magnetic albumin microspheres in rats [J]. J Pharm Sci, 1989,78:290-294.
8Widder KJ, Marino PA, Morris RM, et al. Selective targeting of magnetic albumin microsheres to the Yoshide Sarcoma: Ultrastructural evaluation of microsphere disposition[J]. Eur J Cancer Clin Oncol, 1983,19(1):141-147.
9David SS. Biomedical application of nanotechnology-implications for drug targeting and gene Therapy[J ]. Trend Biotechnol, 1997,15(6) :217-224.
10Kubiak C, Couvreur P, Manil L, et al. Increased cytotoxicity of nanoparticle-carried adriamycin in vitro and potentiation by verapamil and amiodarone[J]. Biomaterial, 1989, 10(8):553-557.
